Stock comparison
Eli Lilly
SANUWAVE Health
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
LLY
Eli Lilly
Market cap
$946.37B
Sector
Healthcare
SNWV
SANUWAVE Health
Market cap
$137.85M
Sector
Healthcare
Overall winner
Eli Lilly LLY
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | LLY | SNWV | Winner |
|---|---|---|---|
| Warren Buffett | 65B | 38D | LLY |
| Benjamin Graham | 76B | 50C | LLY |
| Philip Fisher | 75B | 54C | LLY |
| Peter Lynch | 64C | 100A | SNWV |
| Joel Greenblatt | 68B | 57C | LLY |
| Charlie Munger | 75B | 51C | LLY |
| Terry Smith | 66B | 44D | LLY |
Side-by-side metrics
| Metric | LLY | SNWV |
|---|---|---|
| Market cap | $946.37B | $137.85M |
| P/E (TTM) | 35.6x | 8.6x |
| EV/EBIT | 33.2x | 27.1x |
| ROIC (TTM) | 32.06% | 11.43% |
| Gross margin | 83.51% | 74.75% |
| Net margin | 34.98% | 36.21% |
| Revenue CAGR 5y | 23.17% | 35.65% |
| EPS CAGR 5y | 40.81% | - |
| Debt / Equity | 1.4x | 3.9x |
| Dividend yield | 0.64% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
LLY leads on
- Dividend yield0.64%vs 0.0%+100%
- Market cap$946.37Bvs $137.85M+100%
- Debt / Equity1.4xvs 3.9x+64%
- ROIC (TTM)32.06%vs 11.43%+64%
SNWV leads on
- P/E (TTM)8.6xvs 35.6x+76%
- Revenue CAGR 5y35.65%vs 23.17%+35%
- EV/EBIT27.1xvs 33.2x+18%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.